Share the Science: Drs. Malhorta & Zhou - Potential Cord Blood Cell Therapy for Preterm Brain Injury
Save the Cord Foundation and WellSky are proud to welcome Dr. Atul Malhorta and Dr. Lindsay Zhou as our featured speakers for the next edition of Share the Science on Wednesday, August 17th, 2022 at 5pm US Eastern Time / 4pm US Central Time. Join us to hear Dr. Malhorta and Dr. Zhou discuss their research on the potential use of cord blood in cell therapy to treat brain injury in preterm infants.
Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.
Cell Therapy for Brain Injury:
Dr. Atul Malhotra
Senior Consultant Neonatologist and Head of the Early Neurodevelopment Clinic at Monash Children's Hospital and Associate Professor (Research) & NHMRC Fellow in the Department of Paediatrics, Monash University.
Associate Professor Atul Malhotra is a Senior Consultant Neonatologist and Head of the Early Neurodevelopment Clinic at Monash Children's Hospital and Associate Professor (Research) & NHMRC Fellow in the Department of Paediatrics, Monash University. He has published over 120 peer-reviewed journal articles, 4 book chapters and his research has attracted over $7.5 million of funding to date. He is also the co-Director of the Newborn Cell Therapies Group at Monash, which has been instrumental in the translation of preclinical therapies from the laboratory to the clinic, including regenerative cell therapies. He led a world-first trial of placental amnion epithelial cells for chronic lung disease of prematurity, and is the Principal Investigator of two cord blood derived cell therapy trials currently recruiting.
Dr. Lindsay Zhou
Consultant Neonatologist at Monash Children's Hospital and a PhD student at the Ritchie Centre and Department of Paediatrics, Monash University.
Dr Lindsay Zhou is a Consultant Neonatologist at Monash Children's Hospital and a PhD student at the Ritchie Centre and Department of Paediatrics, Monash University. Dr. Zhou undertook his paediatric and neonatal training in Melbourne, and also works as a Retrieval Consultant at the Royal Children's Hospital Melbourne. His PhD studies focus on umbilical cord-blood derived cell therapy applications for extremely preterm infants. He is an Associate Investigator on the CordSaFe clinical trial, investigating the safety and feasibility of umbilical cord blood-derived cell collection and administration in infants born at less than 28 weeks.
Share the Science and sharing their valuable insight
on the potential of using cord blood in cell therapy to treat preterm brain injury in enfants.
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.
Write something about yourself. No need to be fancy, just an overview.